Cancer · Austria
Endometrial cancer
How is it diagnosed today? Your family doctor asks about your symptoms and may examine your tummy and vagina; you can ask for a female doctor or nurse. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.7 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Hysterectomy, then radiotherapy or chemo if needed. MedlinePlus
4 medicines are approved for this disease in Austria:
- Dostarlimab (Jemperli) – approved in 2021
- Durvalumab (Imfinzi) – approved in 2018
- Olaparib (Lynparza) – approved in 2014
- Pembrolizumab (Keytruda, Keytruda Qlex) – approved in 2015
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (3)
- Cisplatin (Cisplatine Teva, Cisplatine Viatris) – approved for it in France
- Hydroxyprogesterone caproate (Hydroxyprogesterone Caproate) – approved for it in the US
- Lenvatinib (Lenvima, Lenvatinib Sandoz, Lenvatinib-Teva) – approved for it in the US and Switzerland
Being tested in people
7 open trials in Austria, 341 worldwide. See the trials
- Anlotinib hydrochloride capsule + TQB2450 injection (Phase 3)
- anti-PD1 agent therapy - 1 year (Phase 3)
- anti-PD1 agent therapy - 2 years (Phase 3)
- Bevacizumab (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 1 was in animals and 0 in the lab. See them
No proof it works
Animal worm medicines (ivermectin, fenbendazole) for cancer: not approved, and not enough research in people to know if they help. American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
7 open trials in Austria
Tests BNT323 or chemotherapy in people with recurring HER2-expressing uterine cancer
NCT06340568 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Salzburg – Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
- and 1 more site
Age 18 and over
Contact the trial teamTests sacituzumab tirumotecan with pembrolizumab in endometrial cancer
NCT06952504 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Vienna – Medical University of Vienna
Age 18 and over
Contact the trial teamEIK1005 alone or with pembrolizumab for advanced solid tumors
NCT07262619 · ClinicalTrials.gov
- Linz – Ordensklinikum Linz Elisabethinen
Age 18 and over
Contact the trial teamTests trastuzumab deruxtecan with immunotherapy for HER2-expressing endometrial cancer
NCT06989112 · ClinicalTrials.gov
- Innsbruck – Medizinische Universitaet Innsbruck
- Linz – Kepler Universitaetsklinikum GmbH
- Vienna – Klinik Hietzing
- and 1 more site
Age 18 and over
Contact the trial teamPuxitatug samrotecan compared with chemotherapy in B7-H4-selected endometrial cancer
NCT07044336 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Vienna – Medical University of Vienna
Age 18 and over
Contact the trial teamFollowing early uterine cancer with tiny cancer cells in nearby lymph nodes
NCT06689956 · ClinicalTrials.gov
- Vienna – Medical University of Vienna
No age limit given in the registry
Contact the trial teamNavtemadlin as Maintenance Treatment for Endometrial Cancer After Chemotherapy
NCT05797831 · ClinicalTrials.gov
- Graz – University Hospital Graz, Department of Gynecology and Obstetrics
- Innsbruck – Medizinische Universität Innsbruck
- Vienna – Medizinische Universität Wien
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Available abroad (396 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Tests lighter follow-up treatment for early endometrial cancer with certain tumor gene profiles
NCT05640999 · ClinicalTrials.gov
Countries: Germany, France, Italy and 6 more
- Schwäbisch Hall, Germany – Diak Klinikum Landkreis Schwaebisch Hall
- Lille, France – Centre Oscar Lambret
- Lyon, France – Centre Leon Berard
Age 18 and over
Contact the trial teamTests PLN-101095 with pembrolizumab in adults with advanced solid tumors
NCT06270706 · ClinicalTrials.gov
Countries: Spain, United States
- Barcelona, Spain – START Barcelona Hospital HM Nou Delfos
- Barcelona, Spain – Hospital Universitari Vall d'Hebron - VHIO
- Barcelona, Spain – Hospital Universitari Quirónsalud (NEXT Barcelona)
Age 18 and over
Contact the trial teamLong-term belzutifan treatment for adults with solid tumors or von Hippel-Lindau disease tumors
2025-524160-38-00 · EU Clinical Trials Register
Countries: Belgium, Czechia, Spain and 5 more
- Leuven, Belgium – UZ Leuven
- Olomouc, Czechia – University Hospital Olomouc
- Prague, Czechia – Fakultni Thomayerova nemocnice
Age 18 and over
Contact the trial teamTests CTIM-76 in adults with recurring ovarian cancer and other solid tumors
NCT06515613 · ClinicalTrials.gov
Countries: Spain, France, United Kingdom and 1 more
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Madrid, Spain – Hospital Universitario 12 de Octubre
- Madrid, Spain – Hospital Universitario Fundación Jiménez Díaz
Age 18 and over
Contact the trial teamTests VS-7375 in adults with advanced solid tumors carrying a KRAS G12D mutation
NCT07020221 · ClinicalTrials.gov
Countries: Spain, France, Australia and 1 more
- Barcelona, Spain – Vall d'Hebron Instituto de Oncologia
- Logroño, Spain – START - Rioja Hospital Universitario San Pedro
- Madrid, Spain – START Madrid-FJD
Age 18 and over
Contact the trial teamIDE034 for Advanced Solid Tumors Including Lung, Colorectal, Ovarian and Prostate Cancers
NCT07503808 · ClinicalTrials.gov
Countries: Spain, Georgia, United States
- Madrid, Spain – Hospital Universitario HM Sanchinarro
- Batumi, Georgia – LTD High Technology Hospital Medcenter
- Tbilisi, Georgia – Multiprofile Clinic Consilium Medulla
Age 18 and over
Contact the trial teamLooking for cancer markers in self-collected urine and vaginal samples for gynecological cancers
NCT07902375 · ClinicalTrials.gov
Countries: Belgium
- Edegem, Belgium – University Hospital of Antwerp (UZA)
Age 18 and over
Contact the trial teamTests Sofe-M in adults with selected advanced solid tumors
NCT06400472 · ClinicalTrials.gov
Countries: Spain, France, Italy and 3 more
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
- Madrid, Spain – Hospital Universitario 12 de Octubre
- Valencia, Spain – Hospital Clinico Universitario de Valencia
Age 18 and over
Contact the trial teamTests zanidatamab in adults with HER2-expressing solid tumors that were previously treated
NCT06695845 · ClinicalTrials.gov
Countries: Spain, Georgia, South Korea and 1 more
- Barcelona, Spain – Hospital Clinic de Barcelona
- Barcelona, Spain – Hospital Universitario Vall d'Hebron
- Las Palmas, Spain – Hospital Universitario Insular Gran Canarias
Age 18 and over
Contact the trial teamTests sevabertinib in solid tumors with HER2 gene mutations
NCT06760819 · ClinicalTrials.gov
Countries: Switzerland, Denmark, Spain and 8 more
- Bern, Switzerland – Inselspital Bern - Universitätsklinik für Medizinische Onkologie
- Geneva, Switzerland – Hopitaux Universitaires de Geneve - Oncology Department
- Zurich, Switzerland – UniversitätsSpital Zürich (USZ) - Klinik für Medizinische Onkologie und Hämatologie
Age 18 and over
Contact the trial teamStudies gut bacteria and immunotherapy response in lung, skin and gynecologic cancers
NCT07815873 · ClinicalTrials.gov
Countries: Italy
- Milan, Italy – Istituto Europeo di Oncologia
Age 18 and over
Contact the trial teamTests ADU-1805 alone and with pembrolizumab in advanced solid tumors
NCT05856981 · ClinicalTrials.gov
Countries: Belgium, Spain, United States
- Charleroi, Belgium – Grand Hopital de Charleroi (GHdC) - Hopital Notre Dame
- Madrid, Spain – Hospital General Universitario Gergorio Maranon
- Madrid, Spain – Hosp 12 de Octubre
Age 18 and over
Contact the trial teamCompares Rina-S with standard chemotherapy in endometrial cancer
NCT07166094 · ClinicalTrials.gov
Countries: Belgium, Germany, Denmark and 16 more
- Brussels, Belgium – Saint-Luc University Clinics
- Edegem, Belgium – Antwerp University Hospital
- Gilly, Belgium – Grand Hôpital de Charleroi
Age 18 and over
Contact the trial teamTesting mocertatug rezetecan against chemotherapy in endometrial cancer
NCT07286331 · ClinicalTrials.gov
Countries: United Kingdom, Argentina, Australia and 7 more
- Leicester, United Kingdom – hospital not given
- London, United Kingdom – hospital not given
- Sutton, United Kingdom – hospital not given
Age 18 and over
Contact the trial teamTests MGC026 in people with advanced solid tumors
NCT06242470 · ClinicalTrials.gov
Countries: United Kingdom, Australia, United States
- Oxford, United Kingdom – Oxford University Hospitals NHS Foundation Trust
- Sutton, United Kingdom – The Royal Marsden NHS Foundation Trust
- Auchenflower, Australia – ICON Cancer Centre Wesley
Age 18 and over
Contact the trial teamTests TER-2013 in advanced solid tumors with PI3K pathway changes
NCT07109726 · ClinicalTrials.gov
Countries: Spain, Ireland, Portugal and 2 more
- Barcelona, Spain – START Research Center at Hospital HM Nou Delfos
- Barcelona, Spain – Hospital Universitario General de Catalunya
- Madrid, Spain – START Madrid Fundacion Jimenez Diaz
Age 18 and over
Contact the trial teamShorter radiotherapy after surgery for endometrial cancer using online adaptive technology
NCT07675733 · ClinicalTrials.gov
Countries: United Kingdom
- Sutton, United Kingdom – The Royal Marsden Hospital, Sutton
Age 18 and over
Contact the trial teamTests trastuzumab deruxtecan after surgery for HER2-expressing endometrial cancer
NCT07022483 · ClinicalTrials.gov
Countries: Germany, Spain, France and 12 more
- Detmold, Germany – Klinikum Lippe GmbH
- Dresden, Germany – Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR
- Frankfurt Am Main, Germany – Goethe University Frankfurt
Age 18 and over
Contact the trial teamTests patritumab deruxtecan in adults with several advanced solid tumors
NCT06172478 · ClinicalTrials.gov
Countries: Belgium, Germany, Spain and 13 more
- Brussels, Belgium – Cliniques universitaires Saint-Luc
- Edegem, Belgium – UZA
- Ghent, Belgium – Universitair Ziekenhuis Gent
Age 18 and over
Contact the trial teamTests ifinatamab deruxtecan in several types of recurrent or spreading solid tumors
NCT06330064 · ClinicalTrials.gov
Countries: Belgium, Germany, Spain and 15 more
- Charleroi, Belgium – Grand Hopital de Charleroi
- Leuven, Belgium – UZ Leuven
- Liège, Belgium – Centre Hospitalier Universitaire de Liège
Age 18 and over
Contact the trial teamRadiotherapy for gynecologic cancer that has spread to a few sites
NCT07883798 · ClinicalTrials.gov
Countries: Poland
- Zamość, Poland – Affidea NU-MED Centrum Diagnostyki i Terapii Onkologicznej
Age 18 and over
Contact the trial teamTests ART0380 Pill Alone or With Chemotherapy for Advanced Solid Tumors
NCT04657068 · ClinicalTrials.gov
Countries: Spain, France, United Kingdom and 1 more
- A Coruña, Spain – Hospital Teresa Herrera (CHUAC)
- A Coruña, Spain – Hospital Clínico Universitario de Santiago (CHUS)
- Badalona, Spain – Institut Catala d'Oncologia Badalona, Hospital Germans Trias I Pujol
Age 18 and over
Contact the trial teamUrine and vaginal swab tests to check for womb cancer in Lynch syndrome
NCT07877779 · ClinicalTrials.gov
Countries: United Kingdom
- Edinburgh, United Kingdom – NHS Lothian
Age 18 and over
Contact the trial teamTests botensilimab and balstilimab before surgery in several tumor types
NCT06279130 · ClinicalTrials.gov
Countries: Netherlands
- Amsterdam, Netherlands – Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Age 18 and over
Contact the trial teamTests BNT329 safety in adults with advanced solid tumors expressing CA19-9
NCT07186842 · ClinicalTrials.gov
Countries: Germany, Spain, United Kingdom and 2 more
- Bochum, Germany – St. Josef-Hospital im Katholischen Klinikum Bochum
- München, Germany – Klinikum der Universität München
- Ulm, Germany – Universitaetsklinikum Ulm
Age 18 and over
Contact the trial teamTests AZD8205 alone or combined in advanced solid tumors
NCT05123482 · ClinicalTrials.gov
Countries: Belgium, Spain, United Kingdom and 12 more
- Anderlecht, Belgium – hospital not given
- Leuven, Belgium – hospital not given
- Barcelona, Spain – hospital not given
Age 18 and over
Contact the trial teamTests XmAb541 for safety in people with advanced solid tumors
NCT06276491 · ClinicalTrials.gov
Countries: Belgium, Denmark, Spain and 3 more
- Kortrijk, Belgium – AZ Groeninge
- Leuven, Belgium – UZ Leuven
- Liège, Belgium – CHU de Liège
Age 15 and over
Contact the trial teamTesting radiotherapy with durvalumab after surgery for mismatch-repair deficient endometrial cancer
NCT05255653 · ClinicalTrials.gov
Countries: Belgium, Czechia, Germany and 4 more
- Anderlecht, Belgium – Institut Jules Bordet
- Charleroi, Belgium – Grand Hopital de Charleroi
- Edegem, Belgium – Antwerp University Hospital
Age 18 and over
Contact the trial teamTests BMS-986500 alone or with other drugs in advanced cancers
NCT06997029 · ClinicalTrials.gov
Countries: Denmark, Japan, United States
- Odense C, Denmark – Odense University Hospital
- Hirakata, Japan – Kansai Medical University Hospital
- Kashiwa, Japan – National Cancer Center Hospital East
Age 18 and over
Contact the trial teamTests AZD9574 alone and with other cancer drugs in advanced solid tumours
NCT05417594 · ClinicalTrials.gov
Countries: Germany, Spain, United Kingdom and 4 more
- Bayern, Germany – hospital not given
- Berlin, Germany – hospital not given
- Heidelberg, Germany – hospital not given
Ages 18 to 130
Contact the trial teamTests AZD5335 alone or with other drugs in advanced solid tumors
NCT05797168 · ClinicalTrials.gov
Countries: Germany, Spain, United Kingdom and 9 more
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
- Freiburg im Breisgau, Germany – Medical Center- University of Freiburg
- Hanover, Germany – Medizinische Hochschule Hannover
Ages 18 to 130
Contact the trial teamTests rezatapopt in advanced solid tumors with a TP53 Y220C mutation
NCT04585750 · ClinicalTrials.gov
Countries: Germany, Spain, France and 6 more
- Augsburg, Germany – Universitätsklinikum Augsburg
- Essen, Germany – Universitätsklinikum Essen
- Frankfurt am Main, Germany – Universitätsklinikum Frankfurt
Age 12 and over
Contact the trial teamObserves real-world care of people with advanced endometrial cancer receiving durvalumab
NCT06890273 · ClinicalTrials.gov
Countries: Germany
- Amberg, Germany – hospital not given
- Bad Nauheim, Germany – hospital not given
- Bautzen, Germany – hospital not given
Ages 18 to 130
Contact the trial teamTests MK-5684 against standard treatment in certain solid tumors
2024-519563-18-00 · EU Clinical Trials Register
Countries: Spain
- A Coruña, Spain – Complexo Hospitalario Universitario A Coruña
- L'Hospitalet de Llobregat, Spain – Institut Catala D'oncologia
- Madrid, Spain – Hospital Universitario Ramón y Cajal
Age 18 and over
Contact the trial teamPre-surgery exercise, diet and support for people with gynaecological cancer
NCT04789694 · ClinicalTrials.gov
Countries: Czechia
- Prague, Czechia – Gynecologic Oncology Center in Prague
Ages 18 to 85
Contact the trial teamTests ubamatamab alone or with cemiplimab in recurrent ovarian and uterine cancers
NCT03564340 · ClinicalTrials.gov
Countries: Belgium, Spain, France and 7 more
- Edegem, Belgium – Antwerp University Hospital
- Leuven, Belgium – UZ Leuven
- Badalona, Spain – Institut Catala d'Oncologia
Age 18 and over
Contact the trial teamTests REGN5668 with other drugs in women with ovarian or uterine cancer
NCT04590326 · ClinicalTrials.gov
Countries: Belgium, Spain, France and 2 more
- Leuven, Belgium – UZ Leuven
- Girona, Spain – Institut Català d'Oncologia
- Madrid, Spain – Hospital Universitario Fundación Jiménez Díaz
Age 18 and over
Contact the trial teamDay-hospital assessment of supportive care after gynecological cancer treatment
NCT06553612 · ClinicalTrials.gov
Countries: France
- Besançon, France – CHU Besançon
- Caen, France – François Baclesse
- Clermont-Ferrand, France – Centre Jean Perrin
Age 18 and over
Contact the trial teamOutcomes in Endometrial Cancer With High-Risk Tumor Features but No Muscle Wall Invasion
NCT07838207 · ClinicalTrials.gov
Countries: Spain
- Barcelona, Spain – Hospital Universitari Vall d'Hebron
Age 18 and over
Contact the trial teamTests datopotamab deruxtecan alone or combined with other drugs in advanced solid tumours
NCT05489211 · ClinicalTrials.gov
Countries: Switzerland, Germany, Spain and 11 more
- Basel, Switzerland – hospital not given
- Bellinzona, Switzerland – hospital not given
- Sankt Gallen, Switzerland – hospital not given
Ages 18 to 130
Contact the trial team
Showing 40 of 396. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- Underfunded, Overperforming: Endometrial cancer leads basic and translational science publications per NCI dollar.Gynecol Oncol Rep · 2026-11-03
- In peopleLow MATR3 Expression Is Associated with Poor Prognosis in Endometrial Carcinoma: An Integrated Immunohistochemical and Transcriptomic Analysis.Int J Mol Sci · 2026-10-29
- Sentinel Lymph Node Mapping in Endometrial Cancer: Experience from a Tertiary Referral Center in Türkiye.J Clin Med · 2026-10-29
- ReviewIncidence, Prognosis, and Management of Occult Endometrial Carcinoma After Hysterectomy for Benign Disease: A Systematic Review and Meta-Analysis.Diagnostics (Basel) · 2026-10-22
- Role of Serum HE4, Selected Clinical Features and Diagnostic Prediction Models in Differentiating Benign and Malignant Endometrial Lesions in Polish Women: A Prospective Cohort Study.Cancers (Basel) · 2026-10-30
Is it true?
Saw something on social media? Fact-check it now.
Get screened
For family members and people at higher risk: free checks can find some cancers early, before there are symptoms.
There is no routine screening for this cancer. If you have symptoms or a family history, talk to your doctor.
If several people in your family had cancer, ask your GP whether genetic counselling makes sense for you.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichische Krebshilfe
Free, anonymous counselling at regional centres in every federal state, psycho-oncology and emergency financial aid.
Phone: 01 7966450
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (5)
- ENGAGe - European Network of Gynaecological Cancer Advocacy Groups (ESGO)
ESGO network of 80+ gynaecological cancer patient groups; member list with country filter.
- European Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
- International Gynecologic Cancer Advocacy Network
Advocacy network of the International Gynecologic Cancer Society: annual advocacy summit, education, advocacy directory; free patient education for survivors and carers
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.